AbbVie’s Once-Daily Parkinson’s Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trials

The FDA approved Juvmo (tavapadon), AbbVie’s once-daily Parkinson’s pill. Here’s how it works, which side effects trials found, and what to ask.

Have A Referral?